Form 4: Confluent Director Jonathan Chadwick Granted 8,302 Restricted Stock Units

Sentiment:

Insider Transaction Report


Confluent, Inc. Director Jonathan Chadwick was granted 8,302 restricted stock units of Class A Common Stock on June 11, 2025, increasing his total beneficial ownership to 494,240 shares.

Summary

  • Jonathan Chadwick, a Director of Confluent, Inc. (CFLT), reported a change in beneficial ownership via a Form 4 filing.
  • On June 11, 2025, Mr. Chadwick was granted 8,302 shares of Class A Common Stock.
  • The transaction price was $0, indicating a grant of restricted stock units (RSUs).
  • Following this transaction, Mr. Chadwick beneficially owns a total of 494,240 shares of Class A Common Stock.
  • The granted RSUs are scheduled to vest on the earlier of the date of the 2026 Annual Meeting (or the date immediately prior if his service as a director ends at such meeting) or the first anniversary of the grant date.

Sentiment

Score: 7

Explanation: The grant of restricted stock units to a director is a positive event for the individual and a routine, positive corporate governance practice for the company, aligning director interests with long-term shareholder value.

Positives

  • The grant of 8,302 restricted stock units to Director Jonathan Chadwick aligns his interests with long-term shareholder value.
  • The grant price of $0 is typical for RSU grants, representing compensation rather than a purchase, which is a standard practice for director equity awards.

Future Outlook

The 8,302 restricted stock units granted to Director Jonathan Chadwick are scheduled to vest on the earlier of the date of the 2026 Annual Meeting (or the date immediately prior if his service as a director ends at such meeting) or the first anniversary of the grant date (June 11, 2026).

Industry Context

This Form 4 filing is a routine disclosure of an insider equity grant, which is a common practice for compensating directors in publicly traded technology companies like Confluent. Such grants align director incentives with long-term shareholder value, a standard corporate governance practice across the software and cloud services industry.

Comparison to Industry Standards

  • The grant of restricted stock units (RSUs) to directors is a common compensation practice in the technology sector, aligning director interests with company performance and shareholder value.
  • The vesting schedule (earlier of annual meeting or one year) is typical for director equity grants, providing retention and performance incentives consistent with industry benchmarks.

Related Party Transactions

  • The grant of 8,302 restricted stock units to Jonathan Chadwick, a Director of Confluent, Inc., constitutes a related party transaction as it involves compensation to an insider.

Stakeholder Impact

  • Shareholders: The grant aligns the director's interests with long-term shareholder value, as the value of the RSUs is tied to the company's stock performance.

Next Steps

  • Vesting of the 8,302 restricted stock units on the earlier of the 2026 Annual Meeting or June 11, 2026.

Key Dates

DateDescription
06/11/2025Date of transaction: Grant of 8,302 restricted stock units to Director Jonathan Chadwick.
06/12/2025Date of filing and signature by Attorney-in-Fact.
2026 Annual MeetingPotential vesting date for the granted restricted stock units (earlier of this date or first anniversary of grant).
06/11/2026First anniversary of the grant date, representing a potential vesting date for the restricted stock units.

Recommendation

hold

Keywords

Confluent, CFLT, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU, Director Compensation, Equity Grant, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.